Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00077
|
|||||
| Drug Name |
Brilinta
|
|||||
| Synonyms |
AR-C126532; AZD-6140; Brilique; Ticagrelor; Ticagrelor (USAN/INN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Thrombosis [ICD11: BD71.4, BD72] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H28F2N6O4S
|
|||||
| Canonical SMILES |
CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F
|
|||||
| InChI |
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
|||||
| InChIKey |
OEKWJQXRCDYSHL-FNOIDJSQSA-N
|
|||||
| CAS Number |
CAS 274693-27-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 522.6 | Topological Polar Surface Area | 164 | ||
| Heavy Atom Count | 36 | Rotatable Bond Count | 10 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 12 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103554312
, 123051091
, 124759706
, 126644885
, 126666051
, 135649975
, 136345665
, 137171656
, 139857160
, 14836432
, 14860737
, 152040158
, 152258075
, 160645837
, 160646914
, 162011636
, 163346229
, 163383616
, 164178089
, 164765598
, 165245536
, 170501033
, 171063069
, 172914585
, 174528632
, 175267325
, 175427101
, 185974765
, 189657701
, 198993342
, 211534943
, 223384813
, 223666650
, 224638556
, 228139491
, 24162024
, 247988848
, 249582784
, 249807649
, 249807650
, 249816423
, 251966736
, 251970939
, 252216468
, 45293678
, 49684205
, 57373617
, 77877844
, 92729712
, 96025700
|
|||||
| ChEBI ID |
CHEBI:68558
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Brilinta was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.